Presentation:  Updates in Polycystic Ovary Syndrome to Improve the Fertility Journey
> Pretest


1. According to the updated international guidelines, which hormone can now be used to define polycystic ovarian morphology (PCOM) in diagnosing PCOS?

a. Luteinizing hormone (LH)

b. Anti-Müllerian hormone (AMH)

c. Follicle-stimulating hormone (FSH)

d. Progesterone

2. A 36-year-old obese woman with PCOS diagnosed at age 24 presents to your infertility practice. She has been taking combined oral contraceptive pills since her diagnosis. She reports her BMI is 36 and she is otherwise healthy. She now desires to get pregnant and is coming to you for advice regarding next steps. Which of the following tests is not indicated in her preconception evaluation?

a. Ovarian ultrasound

b. Endometrial biopsy

c. Serum testosterone

d. Fasting glucose and lipid levels

e. AMH